40
Views
20
CrossRef citations to date
0
Altmetric
Articles

Experimental Studies on Synergism Between Aminoglycosides and the Antimicrobial Antiinflammatory Agent Diclofenac Sodium

Pages 47-53 | Published online: 18 Jul 2013

References

  • Dastidar SG, Basu S, Annadurai S, Chakrabarty AN. In vitro and in vivo anti-bacterial activity of the antiinflammatory agent diclofenac sodium. Recent Advances in chemotherapy, Proceedings of the 18th Int Congress Chemotherapy, Stockholm, Sweden, edited by Einhorn J, Nord CE, Norby SR. Washington D. C.: American Soc. Microbiol. 1994: 339-340.
  • Annadurai S, Basu S, Ray S, Dastidar Sc, Chakrabarty AN. Antimicrobial activity of the antiinflammatory agent diclofenac sodium. Indian J Exp Biol 1998; 36: 86–90.
  • Dastidar SG, Saha PK, Sanyamat B, Chakrabarty AN. Antibacterial activity of ambodryl and benadryl. J Appl Bact 1976; 41: 209–14.
  • Chattopadhyay D, Dastidar Sc, Chakrabarty AN. Antimicrobial property of methdilazine and its synergism with antibiotics and some chemotherapeutic agents. Arzneim Forsch/Drug Res 1988; 38: 869–72.
  • Chakrabarty AN, Acharya DP, Neogi DK, Dastidar SG. Drug interaction of some non-conventional antimicrobial chemotherapeutic agents with special reference to promet-hazine. Indian J Med Res 1989; 89: 233–7.
  • Dastidar SG, Jairaj J, Mookerjee M, Chakrabarty AN. Studies on antimicrobial effect of the antihistaminic phenoth-iazine trimeprazine tartrate. Acta Microbiol Immun Hung 1997; 44: 241–7.
  • Dash SK, Dastidar SG, Chakrabarty AN. Antibacterial property of promazine hydrochloride. Indian J Exp Biol 1977; 15: 324–6.
  • Manna KK, Dastidar S. The antihypertensive drug pro-pranolol hydrochloride (carditap): its antibacterial property. Proceedings National Congress IAMM (Image India, Calcutta), 1984; 137-141.
  • Dastidar SG, Mondal U, Niyogi S, Chakrabarty AN. Antibacterial property of methyl-DOPA and development of cross-resistance in m-DOPA mutants. Indian J Med Res 1986; 84: 142–7.
  • Molnar J, Mandi Y, Holland IB, Schneider G. Anti-bacterial effect, plasmid curing activity and chemical structure of some tricyclic compounds. Acta Microbiol Acad Sci Hung 1977; 24: 1–6.
  • Kristiansen JE, Mortensen I. Antibacterial effect of four phenothiazines. Pharm Toxicol 1987; 60: 100–3.
  • Kristiansen JE. The antimicrobial activity of non-antibi-otics. Acta Pathol Microbiol Immun Scand 1992; 100 (Suppl): 7-19.
  • Dastidar SG, Chaudhury A, Annadurai S, Ray S, Mookerjee M, Chakrabarty AN. In vitro and in vivo antimicro-bial action of fluphenazine. J Chemother 1995; 7: 201–6.
  • Motohashi N, Sakagami H, Komatsu N, Fujimaki M, Wada C, Molnar J. Induction of anti-Escherichia coli activity in mice by phenothiazines, benzo(a)phenothiazines and benz(c)acridines. In vivo 1992; 6: 585–8.
  • Ray S, Chattopadhyay D, Dastidar SG, Chakrabarty AN. Studies on synergism between penicillins and ambodryl (bromodiphenhydramine HCl), an antihistamine with antimi-crobial property. Indian J Exp Biol 1990; 28: 253–8.
  • Dastidar SG, Chakrabarty P, Mookerjee M, Ganguly M, Chakrabarty AN. Studies on the existence of synergism between different antibiotics and a phenothiazine tranquiliser, possessing antimicrobial property. Acta Microbiol Immun Hung 1994; 41: 41–9.
  • Guha Thakurta A, Mandal SK, Ganguly K, Dastidar Sc, Chakrabarty AN. A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine. Acta Microbiol Immun Hung 2000; 47: 21–8.
  • Garrod LP, Lambert HP, O'Grady F. Antibiotic and chemotherapy. London: Churchill Livingstone, 1973: 282–6.
  • Cruickshank R, Duguid JP, Marmion BP, Swain RHA. Medical Microbiology Vol. 2, London: Churchill Livingstone, 1975: 195.
  • Krogstad DJ, Moellering RCJr. Combinations of antibi-otics, mechanism of interaction against bacteria. In: Antibiotics in Laboratory Medicine, fifth edition (Lorian V, ed.), Baltimore: Williams and Wilkins, 1980: 298-341.
  • Crossland J. Lewis's Pharmacology, London: Churchill Livingstone, 1980: 834-5.
  • Gilman AG, Rail T, Nies AS, Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York: Pergamon Press, 1990: Vol I, p. 669; Vol II, p. 1108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.